Infant Bacterial Therapeutics AB
Developing novel biotherapeutics for premature infant diseases through rigorous clinical trials.
Yleiskatsaus
- 5–9
- Työntekijät
- ≤1t SEK
- Liikevaihto
- 2011
- Perustettu
Avainpäättäjät
Staffan Strömberg
Chief Executive Officer
Sanjiv Sharma
Head of Medical Affairs
Margareta Hagman
Board Member
Sebastian Jahreskog
Member of the Nominating Committee
+11 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Infant Bacterial Therapeutics AB (IBT) is a specialized pharmaceutical company focused on developing and commercializing novel drugs specifically targeting diseases affecting premature infants. The company addresses significant unmet medical needs, such as Necrotizing Enterocolitis (NEC), gastroschi...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Tillverkning av läkemedel
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556873858601
Päättäjät
15 yhteystietoa FunnelfeedrissäStaffan Strömberg
Chief Executive Officer
Sanjiv Sharma
Head of Medical Affairs
Margareta Hagman
Board Member
Sebastian Jahreskog
Member of the Nominating Committee
David Dangoor
Chairman of the Nominating Committee
Anders Kronström
Chief Operating Officer
Eva Idén
Board Member
Anthon Jahreskog
Board Member
Maria Ekdahl
Chief Financial Officer
Jannis Kitsakis
Member of the Nominating Committee
Peter Rothschild
Chairman of the Board
Thomas J. Schnitzer
Chief Scientific Officer
Kristina Sjöblom Nygren
Board Member
Muut yhteyshenkilöt
Nigel Titford
Press Contact
Josef Neu
Medical Advisor Neonatology
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
BioGaia Pharma AB
0 työntekijätDeveloping and out-licensing novel biotherapeutic platforms from microbiome research.
iCoat Medical AB
1–4 työntekijätDeveloping drugs to improve organ transplantation outcomes globally.
Disruptive Pharma AB (publ)
5–9 työntekijätSwedish biotech developing novel kidney disease therapies based on proprietary peptides.
OxThera Intellectual Property AB
0 työntekijätDeveloping novel biotherapies for rare kidney diseases like Primary Hyperoxaluria.
iCoat Medical Operations AB
Developing drugs to improve organ transplantation outcomes globally.
Selaa lisää
Kysymyksiä yrityksestä Infant Bacterial Therapeutics AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo